Centessa Pharmaceuti...
NasdaqGS:CNTA
$ 27,58
$-1,12 (-3,90%)
27,58 $
$-1,12 (-3,90%)
End-of-day quote: 03/30/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-1,76
Earnings Per Share
$0,00
Revenue Per Share
0,00%
Operating Margin %
$4,03 B
Market Cap
$0,11 B
Long-Term Debt
Earnings Per Share
$-1,76
Revenue Per Share
$0,00
Operating Margin %
0,00%
Market Cap
$4,03 B
Long-Term Debt
$0,11 B

Financials

Year Year 2025 2024 2023 2022 2020
EPS Earnings Per Share $-2,06 $-2,06 $-1,57 $-2,31 $-0,40
Earnings Earnings $-274,35M $-274,35M $-157,49M $-0,00M $-0,00M
RPS Revenue Per Share $0,00 $0,00 $0,07 N/A N/A
Revenue Revenue $0,00M $0,00M $6,85M $0,00M $0,00M
OCF Operating Cash Flow $-142,06M $-142,06M $-160,34M $0,00M $0,00M
FCF Free Cash Flow $-188,50M $-142,09M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 0,00% 0,00% 100,00% 0,00% 0,00%
FCFS Free Cash Flow Per Share $0,00 $-1,24 $-1,67 $-2,16 $-0,71
LT Debt Long-Term Debt $108,94M $108,94M $75,70M $69,80M N/A
Sha. Stocks 133,18M 133,18M 100,31M 94,6M 0M
×